...
首页> 外文期刊>International Scholarly Research Notices >In VivoCiprofloxacin Release from Hydroxyapatite-Based Bone Implants in Rabbit Tibia: A Preliminary Study
【24h】

In VivoCiprofloxacin Release from Hydroxyapatite-Based Bone Implants in Rabbit Tibia: A Preliminary Study

机译:兔胫骨羟基磷灰石基骨植入物中体内环丙沙星释放的初步研究

获取原文

摘要

The present study deals with the preliminary evaluation ofin vivociprofloxacin release from HAp-ciprofloxacin bone implants in rabbit tibia. The HAp-ciprofloxacin implants (2×2.5 mm) were prepared using various HAp-ciprofloxacin composites synthesized by precipitation technique and 1.5% w/v guar gum as a binder. 5 implants were implanted in artificial cortical bone window at the right proximal tibia of each rabbit. After 3- and 6-day intervals, the rabbits were euthanized. Bone marrow and serum concentrations of ciprofloxacin were determined from the harvested tibia using HPLC method. The results displayed the availability of elevated local antibiotic concentration at the implanted site with the limitation of systemic antibiotic exposure, which can be useful to minimize the risk of systemic toxicity-related side effects. This study is the preliminary investigation of the suitability ofin vivociprofloxacin release from HAp-ciprofloxacin bone implants in rabbit tibia, after implantation, and these implants can be useful for the treatment of bacterial bone infections like osteomyelitis.
机译:本研究涉及从兔胫骨HAp-环丙沙星骨植入物中体内环丙沙星释放的初步评估。使用通过沉淀技术合成的各种HAp-环丙沙星复合材料和1.5%w / v瓜尔胶作为粘合剂,制备了HAp-环丙沙星植入物(2×2.5mm)。在每只兔子的右胫骨近端的人造皮质骨窗中植入5个植入物。在3天和6天的间隔后,将兔子安乐死。使用HPLC方法从收获的胫骨中测定骨髓和环丙沙星的血清浓度。结果显示,在全身性抗生素暴露的限制下,可在植入部位提高局部抗生素浓度,这可用于最大程度地降低全身毒性相关副作用的风险。这项研究是对植入后的兔胫骨HAp-环丙沙星骨植入物中体内环丙沙星释放的适用性的初步调查,这些植入物可用于治疗细菌性骨感染,如骨髓炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号